Has participated in:
-
Functional correction of X-SCID by targeted gene editing in pluripotent stem cells
-
Targeted genome editing restores T cell differentiation in a humanized X-SCID pluripotent stem cell disease model
-
Targeted multi-epitope switching enables straightforward positive/negative selection of CAR T cells
-
CRISPR-Cas9 based gene editing of the immune checkpoint NKG2A enhances NK cell mediated cytotoxicity against multiple myeloma